A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric Cancer

NCT01461057 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Capecitabine
DRUG: Cisplatin
DRUG: Pertuzumab
DRUG: Pertuzumab
DRUG: Trastuzumab

Sponsor

Hoffmann-La Roche